Literature DB >> 17996722

Monitoring lysosomal fusion in electrofused hybridoma cells.

Mateja Gabrijel1, Marko Kreft, Robert Zorec.   

Abstract

Dendritic and tumor cells are fused to produce hybridoma cells, which are considered to be used as cellular vaccines to treat cancer. Previous strategies for hybridoma cell production were based on the quantification of the electrofusion yield by labeling the cytoplasm of both parental cell types. However, a better physiological strategy would be to label subcellular structures related directly to the antigen presentation process. Therefore, we here electrofused the same amount of CHO cells stained with red and green fluorescent dextrans and have monitored the yield of hybridoma cell formation by measuring the fusion of red and green late endocytic organelles that are involved in antigen presentation. By using confocal microscopy, the level of fused, fluorescently labelled late endocytic compartments in a single hybridoma cell was determined. The results demonstrate that organellar fusion occurs in hybridomas, which is time- and temperature-dependent. This approach therefore provides a new method for the hybridoma cell vaccine evaluation, which is based on the intracellular physiological mechanism of antigen presentation.

Entities:  

Mesh:

Year:  2007        PMID: 17996722     DOI: 10.1016/j.bbamem.2007.10.013

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

1.  Fused late endocytic compartments and immunostimulatory capacity of dendritic-tumor cell hybridomas.

Authors:  Mateja Gabrijel; Martina Bergant; Marko Kreft; Matjaz Jeras; Robert Zorec
Journal:  J Membr Biol       Date:  2009-05-06       Impact factor: 1.843

2.  Analysis of confocal images using variable-width line profiles.

Authors:  Marko Kreft; Mateja Prebil; Helena H Chowdhury; Sonja Grilc; Jørgen Jensen; Robert Zorec
Journal:  Protoplasma       Date:  2010-03-15       Impact factor: 3.356

3.  Cell-cell electrofusion: optimization of electric field amplitude and hypotonic treatment for mouse melanoma (B16-F1) and Chinese Hamster ovary (CHO) cells.

Authors:  Marko Usaj; Katja Trontelj; Damijan Miklavcic; Masa Kanduser
Journal:  J Membr Biol       Date:  2010-07-14       Impact factor: 1.843

4.  Survival of castration-resistant prostate cancer patients treated with dendritic-tumor cell hybridomas is negatively correlated with changes in peripheral blood CD56bright CD16- natural killer cells.

Authors:  Helena Haque Chowdhury; Simon Hawlina; Mateja Gabrijel; Saša Trkov Bobnar; Marko Kreft; Gordan Lenart; Marko Cukjati; Andreja Nataša Kopitar; Nataša Kejžar; Alojz Ihan; Luka Ležaič; Marko Grmek; Andrej Kmetec; Matjaž Jeras; Robert Zorec
Journal:  Clin Transl Med       Date:  2021-08

5.  IFN-γ-induced increase in the mobility of MHC class II compartments in astrocytes depends on intermediate filaments.

Authors:  Nina Vardjan; Mateja Gabrijel; Maja Potokar; Urban Svajger; Marko Kreft; Matjaž Jeras; Yolanda de Pablo; Maryam Faiz; Milos Pekny; Robert Zorec
Journal:  J Neuroinflammation       Date:  2012-06-26       Impact factor: 8.322

Review 6.  Dendritic cell-based vaccine prolongs survival and time to next therapy independently of the vaccine cell number.

Authors:  Simon Hawlina; Helena H Chowdhury; Tomaž Smrkolj; Robert Zorec
Journal:  Biol Direct       Date:  2022-02-23       Impact factor: 4.540

Review 7.  Astrocytic vesicle mobility in health and disease.

Authors:  Maja Potokar; Nina Vardjan; Matjaž Stenovec; Mateja Gabrijel; Saša Trkov; Jernej Jorgačevski; Marko Kreft; Robert Zorec
Journal:  Int J Mol Sci       Date:  2013-05-27       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.